202 related articles for article (PubMed ID: 26664908)
41. Inhibitory mechanisms of low concentrations of oxidized low-density lipoprotein on platelet aggregation.
Chou DS; Chan CH; Hsiao G; Shen MY; Tsai YJ; Chen TF; Sheu JR
J Biomed Sci; 2006 May; 13(3):333-43. PubMed ID: 16283430
[TBL] [Abstract][Full Text] [Related]
42. Flow cytometry analysis of porcine platelets: optimized methods for best results.
Krajewski S; Kurz J; Wendel HP; Straub A
Platelets; 2012; 23(5):386-94. PubMed ID: 22035358
[TBL] [Abstract][Full Text] [Related]
43. The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment.
Mobarrez F; Abraham-Nordling M; Aguilera-Gatica K; Friberg I; Antovic A; Pisetsky DS; Jörneskog G; Wallen H
Clin Endocrinol (Oxf); 2016 May; 84(5):729-35. PubMed ID: 26252432
[TBL] [Abstract][Full Text] [Related]
44. Extracellular Microvesicle Production by Human Eosinophils Activated by "Inflammatory" Stimuli.
Akuthota P; Carmo LA; Bonjour K; Murphy RO; Silva TP; Gamalier JP; Capron KL; Tigges J; Toxavidis V; Camacho V; Ghiran I; Ueki S; Weller PF; Melo RC
Front Cell Dev Biol; 2016; 4():117. PubMed ID: 27833910
[TBL] [Abstract][Full Text] [Related]
45. Characterization of Microvesicles Released from Human Red Blood Cells.
Nguyen DB; Ly TB; Wesseling MC; Hittinger M; Torge A; Devitt A; Perrie Y; Bernhardt I
Cell Physiol Biochem; 2016; 38(3):1085-99. PubMed ID: 26938586
[TBL] [Abstract][Full Text] [Related]
46. Elevated concentration of microvesicles isolated from peripheral blood in breast cancer patients.
Galindo-Hernandez O; Villegas-Comonfort S; Candanedo F; González-Vázquez MC; Chavez-Ocaña S; Jimenez-Villanueva X; Sierra-Martinez M; Salazar EP
Arch Med Res; 2013 Apr; 44(3):208-14. PubMed ID: 23506723
[TBL] [Abstract][Full Text] [Related]
47. Aβ42 Protofibrils Interact with and Are Trafficked through Microglial-Derived Microvesicles.
Gouwens LK; Ismail MS; Rogers VA; Zeller NT; Garrad EC; Amtashar FS; Makoni NJ; Osborn DC; Nichols MR
ACS Chem Neurosci; 2018 Jun; 9(6):1416-1425. PubMed ID: 29543435
[TBL] [Abstract][Full Text] [Related]
48. Characterization of Microvesicles in Septic Shock Using High-Sensitivity Flow Cytometry.
Lehner GF; Harler U; Haller VM; Feistritzer C; Hasslacher J; Dunzendorfer S; Bellmann R; Joannidis M
Shock; 2016 Oct; 46(4):373-81. PubMed ID: 27206273
[TBL] [Abstract][Full Text] [Related]
49. The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR
Zeibig S; Büttcher M; Goebel S; Pauli J; Hunger A; Ungerer M; Gawaz M; Münch G
Cell Physiol Biochem; 2019; 52(4):681-695. PubMed ID: 30921507
[TBL] [Abstract][Full Text] [Related]
50. Postprandial Increase in Blood Plasma Levels of Tissue Factor-Bearing (and Other) Microvesicles Measured by Flow Cytometry: Fact or Artifact?
Mørk M; Nielsen MH; Bæk R; Jørgensen MM; Pedersen S; Kristensen SR
TH Open; 2018 Apr; 2(2):e147-e157. PubMed ID: 31249938
[TBL] [Abstract][Full Text] [Related]
51. Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich Plasma.
Frelinger AL; Gerrits AJ; Garner AL; Torres AS; Caiafa A; Morton CA; Berny-Lang MA; Carmichael SL; Neculaes VB; Michelson AD
PLoS One; 2016; 11(8):e0160933. PubMed ID: 27556645
[TBL] [Abstract][Full Text] [Related]
52. p38 mitogen-activated protein kinase regulates mitochondrial function and microvesicle release in riboflavin- and ultraviolet light-treated apheresis platelet concentrates.
Chen Z; Schubert P; Bakkour S; Culibrk B; Busch MP; Devine DV
Transfusion; 2017 May; 57(5):1199-1207. PubMed ID: 28236306
[TBL] [Abstract][Full Text] [Related]
53. Significance of membrane glycoproteins in platelet interaction with oxidized low-density lipoprotein.
Takahashi Y; Fuda H; Yanai H; Akita H; Shuping H; Chiba H; Matsuno K
Semin Thromb Hemost; 1998; 24(3):251-3. PubMed ID: 9701456
[TBL] [Abstract][Full Text] [Related]
54. Microvesicles generated following traumatic brain injury induce platelet dysfunction via adenosine diphosphate receptor.
Martin GE; Pugh AM; Moran R; Veile R; Friend LA; Pritts TA; Makley AT; Caldwell CC; Goodman MD
J Trauma Acute Care Surg; 2019 Apr; 86(4):592-600. PubMed ID: 30614923
[TBL] [Abstract][Full Text] [Related]
55. Unresolved clinical aspects and safety hazards of blood derived- EV/MV in stored blood components: From personal memory lanes to newer perspectives on the roles of EV/MV in various biological phenomena.
Seghatchian J; Amiral J
Transfus Apher Sci; 2016 Aug; 55(1):10-22. PubMed ID: 27522103
[TBL] [Abstract][Full Text] [Related]
56. High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications.
Bergen K; Mobarrez F; Jörneskog G; Wallén H; Tehrani S
Thromb Res; 2020 Dec; 196():78-86. PubMed ID: 32853980
[TBL] [Abstract][Full Text] [Related]
57. Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro.
Yang SH; Li YT; Du DY
Thromb Res; 2013; 132(6):702-11. PubMed ID: 24144446
[TBL] [Abstract][Full Text] [Related]
58. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3.
Wintergerst ES; Jelk J; Rahner C; Asmis R
Eur J Biochem; 2000 Oct; 267(19):6050-9. PubMed ID: 10998066
[TBL] [Abstract][Full Text] [Related]
59. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients.
Janabi M; Yamashita S; Hirano K; Sakai N; Hiraoka H; Matsumoto K; Zhang Z; Nozaki S; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1953-60. PubMed ID: 10938017
[TBL] [Abstract][Full Text] [Related]
60. Isolation and Characterization of Microvesicles from Peripheral Blood.
Menck K; Bleckmann A; Schulz M; Ries L; Binder C
J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
